Connection

Arunaloke Chakrabarti to Risk Factors

Back to Details
This is a "connection" page, showing publications Arunaloke Chakrabarti has written about Risk Factors.
Arunaloke Chakrabarti
Connection Strength
0.122
Risk Factors
  1. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med Mycol. 2019 Jun 01; 57(4):395-402.
    View in: PubMed
    Score: 0.025
  2. Gastrointestinal mucormycosis in apparently immunocompetent hosts-A review. Mycoses. 2018 Dec; 61(12):898-908.
    View in: PubMed
    Score: 0.023
  3. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017 11; 17(11):e357-e366.
    View in: PubMed
    Score: 0.022
  4. Mucormycosis at a tertiary care centre in Gujarat, India. Mycoses. 2017 Jun; 60(6):407-411.
    View in: PubMed
    Score: 0.021
  5. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Mycopathologia. 2021 Dec; 186(6):739-754.
    View in: PubMed
    Score: 0.007
  6. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature. Mycopathologia. 2021 May; 186(2):289-298.
    View in: PubMed
    Score: 0.007
  7. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver Int. 2019 03; 39(3):503-513.
    View in: PubMed
    Score: 0.006
  8. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017 06 01; 72(6):1794-1801.
    View in: PubMed
    Score: 0.005
  9. Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med. 2017 Sep; 43(9):1225-1238.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.